Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Wealth building strategies vary by income level. Discover tailored approaches that align with your financial circumstances for better results.
23,860 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
A fresh SummerFi attack on its automated Lazy Summer vaults raises questions about AI-driven risk in DeFi as guardian...
The Ethereum Foundation has begun staking a portion of its treasury, deploying 2,016 ETH as part of a broader move in...
Momentum-driven strategies can help investors ride strong market trends. This guide explains how two Vanguard ETFs us...
Binance unveils new cross-margin pairs for DOGE, ADA and other altcoins, alongside selective delistings. Traders resp...
Global security priorities and rising defense budgets spotlight the best aerospace defense stocks. Here’s a timely lo...
XRP holders can now earn yield from a native DeFi setup, as Flare and Xaman unveil a one-click integration. Two more ...
As Alphabet shifts its advertising footprint and data strategy, Disney investors just really need to understand the p...
Oracle reports an 84% jump in cloud IaaS revenue and a customer-friendly BYOC GPU program as DCLA argues the company ...
Evernorth moves to go public through a SPAC merger, aiming to convert XRP exposure into a participatory, yield-genera...
Grayscale filed with the SEC to launch the HYPE ETF, which would trade on Nasdaq under GHYP if approved. The fund wou...
Global fertilizer supply disruptions push prices higher, threatening farm budgets and consumer costs in the United St...